|
|
Volumn 2, Issue 1, 2005, Pages
|
|
Phase 1 trial of oscillating field stimulation for complete spinal cord injury in humans.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
METHYLPREDNISOLONE;
ACUTE DISEASE;
CONVALESCENCE;
ELECTROMAGNETIC FIELD;
ELECTROSTIMULATION THERAPY;
HOSPITALIZATION;
HUMAN;
INSTRUMENTATION;
MULTIMODALITY CANCER THERAPY;
NERVE FIBER;
NERVE REGENERATION;
NOTE;
PHASE 1 CLINICAL TRIAL;
PHYSIOLOGY;
SPINAL CORD INJURY;
ACUTE DISEASE;
ANTI-INFLAMMATORY AGENTS;
AXONS;
CLINICAL TRIALS, PHASE I;
COMBINED MODALITY THERAPY;
ELECTRIC STIMULATION THERAPY;
ELECTROMAGNETIC FIELDS;
HUMANS;
METHYLPREDNISOLONE;
NERVE REGENERATION;
RECOVERY OF FUNCTION;
SEVERITY OF ILLNESS INDEX;
SPINAL CORD INJURIES;
|
|
EID: 13844256897
PISSN: 15475654
EISSN: None
Source Type: Journal
DOI: 10.3171/spi.2005.2.1.0001 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
